171
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Optimization Studies on Floating Multiparticulate Gastroretentive Drug Delivery System of Famotidine

&
Pages 1201-1208 | Published online: 20 Oct 2008

REFERENCES

  • L. V. Allen, N. G. Popovich, and H. C. Ansel. 2004. Ansel's pharmaceutical dosage forms and drug delivery systems. Philadelphia: Lippincott Williams and Wilkins.
  • S. Arora, J. Ali, A. Ahuja, R. K. Khar, and S. Baboota. 2005. Floating drug delivery systems: A review. AAPS Pharm. Sci. Tech. 6 (03):372–390.
  • P. L. Bardonnet, V. Faivre, W. J. Pugh, J. C. Piffaretti, and F. Falson. 2006. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control. Release 111:1–18.
  • S. Bolton. 1997. Pharmaceutical statistics: Practical and clinical applications. New York: Marcel Dekker.
  • S. J. Burns, D. Attwood, and S. G. Barnwell. 1994. Assessment of a dissolution vessel designed for use with floating and erodible dosage forms. Int. J. Pharm. 160:213–218.
  • S. Desai, and S. Bolton. 1993. A floating controlled release drug delivery system: In vitro-in vivo evaluation. Pharm. Res. 10:1321–1325.
  • A. A. Deshpande, C. T. Rhodes, N. H. Shah, and A. W. Malick. 1996. Controlled release drug delivery systems for prolonged gastric residence; an overview. Drug Dev. Ind. Pharm. 22:531–539.
  • K. N. Jain. 2004. Progress in controlled and novel drug delivery systems. New DelhiIndia: CBS publishers and distributors.
  • K. S. Jain, A. M. Acanthi, K. N. Jain, and P. G. Agrawal. 2005. Calcium silicate based microspheres of repaglinide for gastro retentive floating drug delivery: Preparation and in vitro characterization. J. Control. Release 107 (2):300–309.
  • Y. Kawashima, T. Niwa, H. Takeuchi, T. Hino, and Y. Itoh. 1992. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 81:135–140.
  • E. S. Kostewicz, M. Wunderlich, U. Brauns, R. Becker, T. Bock, and J. B. Dressman. 2004. Prediction of precipitation of poorly soluble weak bases upon entry in the small intestine. J.Pharm. Pharmacol. 56:43–51.
  • J. M. Patil, R. S. Hirlekar, P. S. Gide, and V. J. Kadam. 2006. Trends in floating drug delivery system. J. Sci. Ind. Res. 65:11–21.
  • N. W. Read, and K. Sugden. 1987. Gastrointestinal dynamics and pharmacology for the optimum design of controlled release oral dosage forms. CRC Crit. Rev. Ther. Drug. Carrier Syst. 4 (3):221–263.
  • R. C. Rowe, P. J. Sheskey, and S. C. Oven. 2006. Handbook of pharmaceutical excipients. London: Pharmaceutical Press.
  • P. Sriamornsak, N. Thirawong, and S. Puttipipatkhachorn. 2004. Morphology and bouyancy of oil-entrapped calcium pectinate gel beads. AAPS J. Pharm. Sci. Tech (3):E24.
  • S. C. Sweetman. 2002. Martindale: The complete drug reference. London: Pharmaceutical Press.
  • S. P. Vyas, and R. K. Khar. 2002. Controlled drug delivery: Concepts and advances. New DelhiIndia: Vallabh Prakashan.
  • J. Wells. 2002. Pharmaceutical Preformulation: The physicochemical properties of drug substances. M. E. Aulton(Ed.), Pharmaceutics: The science of dosage form design (pp. 113–151). London: Churchill Livingstone.
  • L. Whitehead, J. T. Fell, J. H. Collett, H. L. Sharma, and A. M. Smith. 1998. An in vivo study demonstrating prolonged gastric retention. J. Control. Release 55:3–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.